{
    "2021-05-28": [
        [
            {
                "time": "",
                "original_text": "益方生物忙着上市似乎有点早：无产品、无盈利 研发成果尚存不确定性、募投项目用地也未落实",
                "features": {
                    "keywords": [
                        "益方生物",
                        "上市",
                        "无产品",
                        "无盈利",
                        "研发成果",
                        "不确定性",
                        "募投项目",
                        "用地未落实"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "聚焦IPO | 无产品、无盈利，研发成果尚存不确定性，募投项目用地也未落实，益方生物忙着上市似乎有点早！",
                "features": {
                    "keywords": [
                        "IPO",
                        "益方生物",
                        "无产品",
                        "无盈利",
                        "研发成果",
                        "不确定性",
                        "募投项目",
                        "用地未落实"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "肺癌靶向药物的“速度与激情”",
                "features": {
                    "keywords": [
                        "肺癌",
                        "靶向药物",
                        "速度与激情"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业埃克替尼新适应症申请进入「在审批」",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "埃克替尼",
                        "新适应症",
                        "审批"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业股份有限公司获批8亿美元在香港上市",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "香港上市",
                        "8亿美元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}